ArticleCancer management and research2025

Novel Loop-Structure-Based CD19/CD22 Dual-Target CAR-T Therapy for High-Risk Diffuse Large B-Cell Lymphoma Presenting with Hemophagocytic Lymphohistiocytosis: A Case Report.

Yuan Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.